Volitionrx (VNRX) Net Income towards Common Stockholders (2012 - 2025)
Volitionrx posted quarterly Net Income towards Common Stockholders of $260595.0 for Q4 2025, up 104.5% year-on-year from $127431.5 in Q4 2024, and up 929.05% on a QoQ basis from -$31433.0 in Q3 2025.
Volitionrx (VNRX) has 10 years of Net Income towards Common Stockholders data on file, last reported at $260595.0 in Q4 2025.
- For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 104.5% year-over-year to $260595.0; the trailing twelve-month figure through Dec 2025 stood at -$5.3 million (up 80.49% YoY), and the FY2025 full-year result was $146302.0, up 100.54% from the prior year.
- Net Income towards Common Stockholders for Q4 2025 stood at $260595.0, up from -$31433.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $260595.0 in Q4 2025 and bottomed at -$9.5 million in Q2 2023.
- The 5-year median for Net Income towards Common Stockholders is -$11004.5 (2021), against an average of -$3.4 million.
- The widest annual swing landed in 2022, when Net Income towards Common Stockholders surged 791.1%; it then sank 12177.49% in 2023.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $73088.0 in 2021, then climbed by 28.74% to $94092.0 in 2022, then tumbled by 9344.41% to -$8.7 million in 2023, then surged by 33.4% to -$5.8 million in 2024, then jumped by 104.5% to $260595.0 in 2025.
- The last three Net Income towards Common Stockholders figures came in at $260595.0 (Q4 2025), -$31433.0 (Q3 2025), and $29992.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | 260,595.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 260,595.00 |
| Sep 30, 2025 | -31,433.00 |
| Jun 30, 2025 | 29,992.00 |
| Mar 31, 2025 | -5.52 Mn |
| Dec 31, 2024 | -5.79 Mn |
| Sep 30, 2024 | -5.82 Mn |
| Jun 30, 2024 | -6.99 Mn |
| Mar 31, 2024 | -8.37 Mn |
| Dec 31, 2023 | -8.70 Mn |
| Sep 30, 2023 | -8.37 Mn |
| Jun 30, 2023 | -9.47 Mn |
| Mar 31, 2023 | -8.78 Mn |
| Dec 31, 2022 | 94,092.00 |
| Sep 30, 2022 | 69,305.00 |
| Jun 30, 2022 | 82,302.00 |
| Mar 31, 2022 | 83,977.00 |
| Dec 31, 2021 | 73,088.00 |
| Sep 30, 2021 | 45,065.00 |
| Jun 30, 2021 | 47,539.00 |
| Mar 31, 2021 | 9,424.00 |
| Dec 31, 2020 | 23,783.00 |
| Sep 30, 2020 | 8,050.00 |
| Jun 30, 2020 | 5,779.00 |
| Mar 31, 2020 | -5.80 Mn |
| Dec 31, 2019 | -3.78 Mn |
| Sep 30, 2019 | -4.12 Mn |
| Jun 30, 2019 | -4.09 Mn |
| Mar 31, 2019 | -3.78 Mn |
| Dec 31, 2018 | -4.22 Mn |
| Sep 30, 2018 | -4.42 Mn |
| Jun 30, 2018 | -4.59 Mn |
| Jun 30, 2013 | -1.05 Mn |
| Mar 31, 2013 | -907,797.00 |
| Jun 30, 2012 | -931,466.00 |
| Mar 31, 2012 | -801,740.00 |